DCP2 polyclonal, anti-human, mouse, rat
€385.00
In stock
SKU
252209
Catalog Nr.: 252209
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IHC
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IHC
Protein Family: Enzymes, Chaperones and Folding Catalysts
Pathway and Disease: Folding, Sorting and Degradation
Description:
mRNA-decapping enzyme 2 (DCP2) is necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay. DCP2 plays a role in replication-dependent histone mRNA degradation. DCP2 removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP. DCP2 has higher activity towards mRNAs that lack a poly(A) tail, and has no activity towards a cap structure lacking a RNA moiety.
Alternate Names: mRNA-decapping enzyme 2, hDpc, Nucleoside diphosphate-linked moiety X motif 20, Nudix motif 20, DCP2, NUDT20
Application Notes: E: 1:10,000-1:50,000; WB: 1:100-1:1,000; IHC: 1:50-1:250
Accession No.: Q8IU60
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human DCP2.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4, 2% BSA with 0.09% sodium azide. Antibody was purified by immunogen affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
Pathway and Disease: Folding, Sorting and Degradation
Description:
mRNA-decapping enzyme 2 (DCP2) is necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay. DCP2 plays a role in replication-dependent histone mRNA degradation. DCP2 removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP. DCP2 has higher activity towards mRNAs that lack a poly(A) tail, and has no activity towards a cap structure lacking a RNA moiety.
Alternate Names: mRNA-decapping enzyme 2, hDpc, Nucleoside diphosphate-linked moiety X motif 20, Nudix motif 20, DCP2, NUDT20
Application Notes: E: 1:10,000-1:50,000; WB: 1:100-1:1,000; IHC: 1:50-1:250
Accession No.: Q8IU60
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human DCP2.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4, 2% BSA with 0.09% sodium azide. Antibody was purified by immunogen affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
Is Featured? | No |
---|
Write Your Own Review